Fibrin Glue-Antibiotic Mixture in the Treatment of Anal Fistulae: Experience with 69 Cases

Background/Aims: To investigate the potential value of the use of the fibrin glue-antibiotic mixture in the treatment of anal fistulae. Materials and Methods: This study included 69 patients with idiopathic nonspecific anal fistulae. Patients with IBD (inflammatory bowel disease), TBC, actinomycosis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive surgery 2000-01, Vol.17 (1), p.77-80
Hauptverfasser: Patrlj, Leonardo, Kocman, Branislav, Martinac, Miran, Jadrijević, Stipislav, Šoša, Tomislav, Šebećić, Božidar, Brkljaćić, Boris
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 80
container_issue 1
container_start_page 77
container_title Digestive surgery
container_volume 17
creator Patrlj, Leonardo
Kocman, Branislav
Martinac, Miran
Jadrijević, Stipislav
Šoša, Tomislav
Šebećić, Božidar
Brkljaćić, Boris
description Background/Aims: To investigate the potential value of the use of the fibrin glue-antibiotic mixture in the treatment of anal fistulae. Materials and Methods: This study included 69 patients with idiopathic nonspecific anal fistulae. Patients with IBD (inflammatory bowel disease), TBC, actinomycosis, and cancer were excluded from the study. The microbiological analysis of the discharge of the fistula was done routinely. If there was any doubt about vertical classification of the fistulous tract MR of anal canal was necessary. As regards the vertical disposition, 39 fistulae were classified as intersphincteric and 30 as transsphincteric, and as to the length of the fistulous tract, 24 fistulas had tracts ≤3.5 cm long, and 45 fistulas had tracts >3.5 cm long. All fistulae were first treated with the lavage of the fistulous tract with antibiotic solution until a sterile microbiological finding was obtained. This was followed by electrocoagulation of the fistulous tract with a special probe for the eradication of granulomatous tissue. Finally the fibrin glue-antibiotic mixture (Tisseel, Immuno Ltd., Vienna, Austria) was applied. Results: After a follow-up of 18–36 months (median 28) 18 patients (26%) had a recurrence; among these, intersphincteric fistula recurred in 9 patients (23%) and transsphincteric also in 9 (30%). Regarding the length of the fistulous tract, a fistula with a ≤3.5 cm long tract recurred in 13 patients (54%) and a fistula with a >3.5 cm long tract in 5 (11%). Conclusion: The analysis showed that the success of the treatment of anal fistulae with fibrin glue-antibiotic mixture was independent of the vertical disposition of the fistula, and was dependent on the length of the fistulous tract. Surgical treatment remains a golden standard for simple fistulae with a tract ≤3.5 cm. Anal fistulae with a longer tract usually present a more complex problem and are often more difficult to treat surgically, the use of the fibrin glue-antibiotic complex proved to be a feasible method for those cases. It is a safe, cheap, reproducible, pain-free procedure, which eliminates the possibility of anal incontinence and can be performed under local anesthesia.
doi_str_mv 10.1159/000018804
format Article
fullrecord <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_proquest_miscellaneous_70980560</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70980560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-df1bbdddf7fc63e82f27f6f93d3c842c4834c2af0e77f9529e613bfd09d395aa3</originalsourceid><addsrcrecordid>eNpt0L9P3DAUB3ALFcEVGJgrVRZDpQ4B_0gcm-10cIAEYgAWlsixn4shlxy2I-C_x-UQrRBe3uCPvk_vi9AuJfuUVuqA5EelJOUamtCS0UJJyb-hCWEVL0opxSb6HuN9VlwouoE2KakZkVxM0O3ct8H3-KQboZj2ybd-SN7gC_-cxgA4f6U7wNcBdFpAn_Dg8LTXHZ77mMZOwyE-fl5C8NAbwE8-3WGh8ExHiNto3ekuws773EI38-Pr2WlxfnlyNpueF4ZXVSqso21rrXW1M4KDZI7VTjjFLTeyZKaUvDRMOwJ17VTFFAjKW2eJslxVWvMt9GuVuwzD4wgxNQsfDXSd7mEYY1MTJUklSIZ7n-D9MIZ8TGwY44LUuZWMfq-QCUOMAVyzDH6hw0tDSfO37eaj7Wx_vgeO7QLsf3JV77-NDzr8gfABjq5u3hKapXUZ_fgSrXa8ApCgjUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223607072</pqid></control><display><type>article</type><title>Fibrin Glue-Antibiotic Mixture in the Treatment of Anal Fistulae: Experience with 69 Cases</title><source>MEDLINE</source><source>Karger Journals</source><creator>Patrlj, Leonardo ; Kocman, Branislav ; Martinac, Miran ; Jadrijević, Stipislav ; Šoša, Tomislav ; Šebećić, Božidar ; Brkljaćić, Boris</creator><creatorcontrib>Patrlj, Leonardo ; Kocman, Branislav ; Martinac, Miran ; Jadrijević, Stipislav ; Šoša, Tomislav ; Šebećić, Božidar ; Brkljaćić, Boris</creatorcontrib><description>Background/Aims: To investigate the potential value of the use of the fibrin glue-antibiotic mixture in the treatment of anal fistulae. Materials and Methods: This study included 69 patients with idiopathic nonspecific anal fistulae. Patients with IBD (inflammatory bowel disease), TBC, actinomycosis, and cancer were excluded from the study. The microbiological analysis of the discharge of the fistula was done routinely. If there was any doubt about vertical classification of the fistulous tract MR of anal canal was necessary. As regards the vertical disposition, 39 fistulae were classified as intersphincteric and 30 as transsphincteric, and as to the length of the fistulous tract, 24 fistulas had tracts ≤3.5 cm long, and 45 fistulas had tracts &gt;3.5 cm long. All fistulae were first treated with the lavage of the fistulous tract with antibiotic solution until a sterile microbiological finding was obtained. This was followed by electrocoagulation of the fistulous tract with a special probe for the eradication of granulomatous tissue. Finally the fibrin glue-antibiotic mixture (Tisseel, Immuno Ltd., Vienna, Austria) was applied. Results: After a follow-up of 18–36 months (median 28) 18 patients (26%) had a recurrence; among these, intersphincteric fistula recurred in 9 patients (23%) and transsphincteric also in 9 (30%). Regarding the length of the fistulous tract, a fistula with a ≤3.5 cm long tract recurred in 13 patients (54%) and a fistula with a &gt;3.5 cm long tract in 5 (11%). Conclusion: The analysis showed that the success of the treatment of anal fistulae with fibrin glue-antibiotic mixture was independent of the vertical disposition of the fistula, and was dependent on the length of the fistulous tract. Surgical treatment remains a golden standard for simple fistulae with a tract ≤3.5 cm. Anal fistulae with a longer tract usually present a more complex problem and are often more difficult to treat surgically, the use of the fibrin glue-antibiotic complex proved to be a feasible method for those cases. It is a safe, cheap, reproducible, pain-free procedure, which eliminates the possibility of anal incontinence and can be performed under local anesthesia.</description><identifier>ISSN: 0253-4886</identifier><identifier>EISSN: 1421-9883</identifier><identifier>DOI: 10.1159/000018804</identifier><identifier>PMID: 10720836</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject><![CDATA[Adult ; Cefotaxime - administration & dosage ; Cephalosporins - administration & dosage ; Drug Therapy, Combination - administration & dosage ; Electrocoagulation ; Female ; Fibrin Tissue Adhesive - administration & dosage ; Gentamicins - administration & dosage ; Humans ; Male ; Metronidazole - administration & dosage ; Middle Aged ; Original Paper ; Rectal Fistula - surgery ; Therapeutic Irrigation ; Tissue Adhesives]]></subject><ispartof>Digestive surgery, 2000-01, Vol.17 (1), p.77-80</ispartof><rights>2000 S. Karger AG, Basel</rights><rights>Copyright 2000 S. Karger AG, Basel</rights><rights>Copyright (c) 2000 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-df1bbdddf7fc63e82f27f6f93d3c842c4834c2af0e77f9529e613bfd09d395aa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,2423,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10720836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patrlj, Leonardo</creatorcontrib><creatorcontrib>Kocman, Branislav</creatorcontrib><creatorcontrib>Martinac, Miran</creatorcontrib><creatorcontrib>Jadrijević, Stipislav</creatorcontrib><creatorcontrib>Šoša, Tomislav</creatorcontrib><creatorcontrib>Šebećić, Božidar</creatorcontrib><creatorcontrib>Brkljaćić, Boris</creatorcontrib><title>Fibrin Glue-Antibiotic Mixture in the Treatment of Anal Fistulae: Experience with 69 Cases</title><title>Digestive surgery</title><addtitle>Dig Surg</addtitle><description>Background/Aims: To investigate the potential value of the use of the fibrin glue-antibiotic mixture in the treatment of anal fistulae. Materials and Methods: This study included 69 patients with idiopathic nonspecific anal fistulae. Patients with IBD (inflammatory bowel disease), TBC, actinomycosis, and cancer were excluded from the study. The microbiological analysis of the discharge of the fistula was done routinely. If there was any doubt about vertical classification of the fistulous tract MR of anal canal was necessary. As regards the vertical disposition, 39 fistulae were classified as intersphincteric and 30 as transsphincteric, and as to the length of the fistulous tract, 24 fistulas had tracts ≤3.5 cm long, and 45 fistulas had tracts &gt;3.5 cm long. All fistulae were first treated with the lavage of the fistulous tract with antibiotic solution until a sterile microbiological finding was obtained. This was followed by electrocoagulation of the fistulous tract with a special probe for the eradication of granulomatous tissue. Finally the fibrin glue-antibiotic mixture (Tisseel, Immuno Ltd., Vienna, Austria) was applied. Results: After a follow-up of 18–36 months (median 28) 18 patients (26%) had a recurrence; among these, intersphincteric fistula recurred in 9 patients (23%) and transsphincteric also in 9 (30%). Regarding the length of the fistulous tract, a fistula with a ≤3.5 cm long tract recurred in 13 patients (54%) and a fistula with a &gt;3.5 cm long tract in 5 (11%). Conclusion: The analysis showed that the success of the treatment of anal fistulae with fibrin glue-antibiotic mixture was independent of the vertical disposition of the fistula, and was dependent on the length of the fistulous tract. Surgical treatment remains a golden standard for simple fistulae with a tract ≤3.5 cm. Anal fistulae with a longer tract usually present a more complex problem and are often more difficult to treat surgically, the use of the fibrin glue-antibiotic complex proved to be a feasible method for those cases. It is a safe, cheap, reproducible, pain-free procedure, which eliminates the possibility of anal incontinence and can be performed under local anesthesia.</description><subject>Adult</subject><subject>Cefotaxime - administration &amp; dosage</subject><subject>Cephalosporins - administration &amp; dosage</subject><subject>Drug Therapy, Combination - administration &amp; dosage</subject><subject>Electrocoagulation</subject><subject>Female</subject><subject>Fibrin Tissue Adhesive - administration &amp; dosage</subject><subject>Gentamicins - administration &amp; dosage</subject><subject>Humans</subject><subject>Male</subject><subject>Metronidazole - administration &amp; dosage</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>Rectal Fistula - surgery</subject><subject>Therapeutic Irrigation</subject><subject>Tissue Adhesives</subject><issn>0253-4886</issn><issn>1421-9883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpt0L9P3DAUB3ALFcEVGJgrVRZDpQ4B_0gcm-10cIAEYgAWlsixn4shlxy2I-C_x-UQrRBe3uCPvk_vi9AuJfuUVuqA5EelJOUamtCS0UJJyb-hCWEVL0opxSb6HuN9VlwouoE2KakZkVxM0O3ct8H3-KQboZj2ybd-SN7gC_-cxgA4f6U7wNcBdFpAn_Dg8LTXHZ77mMZOwyE-fl5C8NAbwE8-3WGh8ExHiNto3ekuws773EI38-Pr2WlxfnlyNpueF4ZXVSqso21rrXW1M4KDZI7VTjjFLTeyZKaUvDRMOwJ17VTFFAjKW2eJslxVWvMt9GuVuwzD4wgxNQsfDXSd7mEYY1MTJUklSIZ7n-D9MIZ8TGwY44LUuZWMfq-QCUOMAVyzDH6hw0tDSfO37eaj7Wx_vgeO7QLsf3JV77-NDzr8gfABjq5u3hKapXUZ_fgSrXa8ApCgjUg</recordid><startdate>200001</startdate><enddate>200001</enddate><creator>Patrlj, Leonardo</creator><creator>Kocman, Branislav</creator><creator>Martinac, Miran</creator><creator>Jadrijević, Stipislav</creator><creator>Šoša, Tomislav</creator><creator>Šebećić, Božidar</creator><creator>Brkljaćić, Boris</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200001</creationdate><title>Fibrin Glue-Antibiotic Mixture in the Treatment of Anal Fistulae: Experience with 69 Cases</title><author>Patrlj, Leonardo ; Kocman, Branislav ; Martinac, Miran ; Jadrijević, Stipislav ; Šoša, Tomislav ; Šebećić, Božidar ; Brkljaćić, Boris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-df1bbdddf7fc63e82f27f6f93d3c842c4834c2af0e77f9529e613bfd09d395aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Cefotaxime - administration &amp; dosage</topic><topic>Cephalosporins - administration &amp; dosage</topic><topic>Drug Therapy, Combination - administration &amp; dosage</topic><topic>Electrocoagulation</topic><topic>Female</topic><topic>Fibrin Tissue Adhesive - administration &amp; dosage</topic><topic>Gentamicins - administration &amp; dosage</topic><topic>Humans</topic><topic>Male</topic><topic>Metronidazole - administration &amp; dosage</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>Rectal Fistula - surgery</topic><topic>Therapeutic Irrigation</topic><topic>Tissue Adhesives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patrlj, Leonardo</creatorcontrib><creatorcontrib>Kocman, Branislav</creatorcontrib><creatorcontrib>Martinac, Miran</creatorcontrib><creatorcontrib>Jadrijević, Stipislav</creatorcontrib><creatorcontrib>Šoša, Tomislav</creatorcontrib><creatorcontrib>Šebećić, Božidar</creatorcontrib><creatorcontrib>Brkljaćić, Boris</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patrlj, Leonardo</au><au>Kocman, Branislav</au><au>Martinac, Miran</au><au>Jadrijević, Stipislav</au><au>Šoša, Tomislav</au><au>Šebećić, Božidar</au><au>Brkljaćić, Boris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibrin Glue-Antibiotic Mixture in the Treatment of Anal Fistulae: Experience with 69 Cases</atitle><jtitle>Digestive surgery</jtitle><addtitle>Dig Surg</addtitle><date>2000-01</date><risdate>2000</risdate><volume>17</volume><issue>1</issue><spage>77</spage><epage>80</epage><pages>77-80</pages><issn>0253-4886</issn><eissn>1421-9883</eissn><abstract>Background/Aims: To investigate the potential value of the use of the fibrin glue-antibiotic mixture in the treatment of anal fistulae. Materials and Methods: This study included 69 patients with idiopathic nonspecific anal fistulae. Patients with IBD (inflammatory bowel disease), TBC, actinomycosis, and cancer were excluded from the study. The microbiological analysis of the discharge of the fistula was done routinely. If there was any doubt about vertical classification of the fistulous tract MR of anal canal was necessary. As regards the vertical disposition, 39 fistulae were classified as intersphincteric and 30 as transsphincteric, and as to the length of the fistulous tract, 24 fistulas had tracts ≤3.5 cm long, and 45 fistulas had tracts &gt;3.5 cm long. All fistulae were first treated with the lavage of the fistulous tract with antibiotic solution until a sterile microbiological finding was obtained. This was followed by electrocoagulation of the fistulous tract with a special probe for the eradication of granulomatous tissue. Finally the fibrin glue-antibiotic mixture (Tisseel, Immuno Ltd., Vienna, Austria) was applied. Results: After a follow-up of 18–36 months (median 28) 18 patients (26%) had a recurrence; among these, intersphincteric fistula recurred in 9 patients (23%) and transsphincteric also in 9 (30%). Regarding the length of the fistulous tract, a fistula with a ≤3.5 cm long tract recurred in 13 patients (54%) and a fistula with a &gt;3.5 cm long tract in 5 (11%). Conclusion: The analysis showed that the success of the treatment of anal fistulae with fibrin glue-antibiotic mixture was independent of the vertical disposition of the fistula, and was dependent on the length of the fistulous tract. Surgical treatment remains a golden standard for simple fistulae with a tract ≤3.5 cm. Anal fistulae with a longer tract usually present a more complex problem and are often more difficult to treat surgically, the use of the fibrin glue-antibiotic complex proved to be a feasible method for those cases. It is a safe, cheap, reproducible, pain-free procedure, which eliminates the possibility of anal incontinence and can be performed under local anesthesia.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>10720836</pmid><doi>10.1159/000018804</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0253-4886
ispartof Digestive surgery, 2000-01, Vol.17 (1), p.77-80
issn 0253-4886
1421-9883
language eng
recordid cdi_proquest_miscellaneous_70980560
source MEDLINE; Karger Journals
subjects Adult
Cefotaxime - administration & dosage
Cephalosporins - administration & dosage
Drug Therapy, Combination - administration & dosage
Electrocoagulation
Female
Fibrin Tissue Adhesive - administration & dosage
Gentamicins - administration & dosage
Humans
Male
Metronidazole - administration & dosage
Middle Aged
Original Paper
Rectal Fistula - surgery
Therapeutic Irrigation
Tissue Adhesives
title Fibrin Glue-Antibiotic Mixture in the Treatment of Anal Fistulae: Experience with 69 Cases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T18%3A01%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibrin%20Glue-Antibiotic%20Mixture%20in%20the%20Treatment%20of%20Anal%20Fistulae:%20Experience%20with%2069%20Cases&rft.jtitle=Digestive%20surgery&rft.au=Patrlj,%20Leonardo&rft.date=2000-01&rft.volume=17&rft.issue=1&rft.spage=77&rft.epage=80&rft.pages=77-80&rft.issn=0253-4886&rft.eissn=1421-9883&rft_id=info:doi/10.1159/000018804&rft_dat=%3Cproquest_karge%3E70980560%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223607072&rft_id=info:pmid/10720836&rfr_iscdi=true